X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Torrent Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-18
ADCOCK INGRAM
Jun-14
TORRENT PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,550347-   
Low Rs1,144250-   
Sales per share (Unadj.) Rs354.7103.1-  
Earnings per share (Unadj.) Rs40.1-26.0-  
Cash flow per share (Unadj.) Rs64.2-21.5-  
Dividends per share (Unadj.) Rs14.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs273.180.9-  
Shares outstanding (eoy) m169.22168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.82.9 131.2%   
Avg P/E ratio x33.6-11.5 -292.7%  
P/CF ratio (eoy) x21.0-13.9 -151.3%  
Price / Book Value ratio x4.93.7 133.8%  
Dividend payout %34.90-   
Avg Mkt Cap Rs m227,89750,342 452.7%   
No. of employees `00014.74.3 342.4%   
Total wages/salary Rs m11,3533,160 359.3%   
Avg. sales/employee Rs Th4,083.04,052.9 100.7%   
Avg. wages/employee Rs Th772.3736.0 104.9%   
Avg. net profit/employee Rs Th461.3-1,021.2 -45.2%   
INCOME DATA
Net Sales Rs m60,02117,399 345.0%  
Other income Rs m2,988122 2,452.7%   
Total revenues Rs m63,00917,521 359.6%   
Gross profit Rs m13,493-3,015 -447.5%  
Depreciation Rs m4,086751 544.1%   
Interest Rs m3,085471 654.5%   
Profit before tax Rs m9,310-4,116 -226.2%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,529257 983.3%   
Profit after tax Rs m6,781-4,384 -154.7%  
Gross profit margin %22.5-17.3 -129.7%  
Effective tax rate %27.2-6.2 -434.7%   
Net profit margin %11.3-25.2 -44.8%  
BALANCE SHEET DATA
Current assets Rs m52,62312,743 412.9%   
Current liabilities Rs m52,0227,170 725.5%   
Net working cap to sales %1.032.0 3.1%  
Current ratio x1.01.8 56.9%  
Inventory Days Days120111 107.8%  
Debtors Days Days76124 61.5%  
Net fixed assets Rs m85,0167,428 1,144.5%   
Share capital Rs m84681 1,047.5%   
"Free" reserves Rs m45,3760-   
Net worth Rs m46,22213,656 338.5%   
Long term debt Rs m41,1154,799 856.7%   
Total assets Rs m142,43225,798 552.1%  
Interest coverage x4.0-7.7 -52.0%   
Debt to equity ratio x0.90.4 253.1%  
Sales to assets ratio x0.40.7 62.5%   
Return on assets %6.9-15.2 -45.7%  
Return on equity %14.7-32.1 -45.7%  
Return on capital %14.2-19.8 -71.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,9800-   
CASH FLOW
From Operations Rs m8,9421,485 602.1%  
From Investments Rs m-47,070-456 10,322.0%  
From Financial Activity Rs m34,1744,356 784.6%  
Net Cashflow Rs m-3,6555,385 -67.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.78 Rs / ZAR

Compare TORRENT PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: FRESENIUS KABI ONCO.  DR. DATSONS LABS  SUVEN LIFESCIENCES  AUROBINDO PHARMA  FULFORD INDIA  



Today's Market

Sensex Ends Marginally Higher; Realty and Energy Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector.

Related Views On News

TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended December 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 324.1% YoY). Sales on the other hand came in at Rs 21 bn (up 38.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 12.3% YoY). Sales on the other hand came in at Rs 19 bn (up 32.5% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Is it the Right Time to Buy Mid and Small Caps Now?(The 5 Minute Wrapup)

Mar 6, 2019

Mid and Small Caps have underperformed large caps in the past year. Is the tide about to turn?

The Jet Airways Crisis in 6 Charts(Sector Info)

Mar 5, 2019

What happened to Jet Airways, once among top 3 airlines in India? Is it another Kingfisher in the making? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Mar 18, 2019 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS